Endocrine-Related Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.4 | Q2 | 71.0% | 1.544 | Q1 | 92.4% |
| 2024 | 4.6 | Q1 | 78.2% | 1.674 | Q1 | 93.6% |
| 2023 | 4.1 | Q2 | 68.7% | 1.331 | Q1 | 91.1% |
| 2022 | 3.9 | Q2 | 59.4% | 1.255 | Q1 | 90.6% |
| 2021 | 5.9 | Q2 | 73.9% | 1.416 | Q1 | 92.4% |
| 2020 | — | — | 1.892 | Q1 | 95.0% | |
| 2019 | — | — | 1.545 | Q1 | 93.0% | |
| 2018 | — | — | 1.985 | Q1 | 95.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1351-0088
ISSN
1479-6821
country
GBcoverage
1994-2026